FDA investigator financial disclosure rules should cover company officials only -- Medtronic.
This article was originally published in The Gray Sheet
Executive Summary
CLINICAL INVESTIGATOR FINANCIAL DISCLOSURE: MEDTRONIC PROPOSAL suggests requiring financial disclosure to FDA only "when a physician is a principal owner of a company, is an officer of a company, or on the board of directors of a company whose products are being investigated." The Medtronic proposal was made in recent supplementary comments on FDA's Sept. 22, 1994 proposed rule on financial disclosure by clinical investigators.